测量与治疗相关的副作用负担在严重肌痛性肌痛症
Michael K Hehir1, James F Howard1
1Department of Neurological Sciences, College of Medicine, University of Vermont, Burlington, VT, United States.
International review of neurobiology
|October 16, 2025
概括
测量治疗副作用负担对于肌痛性硬化症 (MG) 患者至关重要. 新疗法需要对不良事件进行仔细评估,以优化治疗价值和患者安全.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 肌痛性骨髓灰质炎 (MG) 的治疗选择正在迅速扩大,有新的FDA批准的疗法和强大的管道.
- 成功的MG治疗是由最小的疾病活性或缓解与有限的不良事件 (AE) 定义的.
- 治疗价值取决于疗效,副作用,治疗负担和成本,安全性是患者和临床医生的关键考虑因素.
研究的目的:
- 突出测量MG治疗副作用负担的重要性.
- 在临床试验和实践中引入三项措施,以促进对副作用负担的评估.
- 为了解决对标准化方法的需求,以比较各种MG治疗的副作用概况.
主要方法:
- 审查目前的MG治疗格局和结果措施.
- 讨论目前评估治疗相关副作用的方法的局限性.
- 确定和描述三种潜在的措施来量化副作用负担.
主要成果:
- 现有的结果指标主要侧重于治疗疗效,不太重视综合副作用负担.
- 目前对皮质类固醇副作用的关注忽视了新型非类固醇MG治疗的独特和潜在的严重特征.
- 提出了三项具体措施,以促进系统测量和比较不同MG疗法的副作用负担.
结论:
- 精确测量副作用负担对于优化MG治疗选择和改善患者生活质量至关重要.
- 需要对不良事件进行标准化的评估,以比较传统和新型MG疗法的整体价值.
- 实施可靠的副作用测量将有助于对严重肌痛性骨髓炎的比较有效性研究和临床决策.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:15Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
01:28Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
01:29Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200